Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
US FDA is looking to modernize clinical trial regulations to promote innovative trial designs and spur evolution in research. The FDA has rolled out a phased implementation for new regulatory requirements, including Laboratory Developed Tests (LDTs). Additionally, China and EU regulators are focusing on innovation, access, and collaboration as key policy aims.
FDA increasing efforts to support CTGT product development https://t.co/0Tl25vNkfu | by @HoganLovells
France Consults On Best Practice Guidelines For Decentralized Trials https://t.co/x0Y6ZSchDY #PinkSheet
Last chance! Join the discussion TODAY on the latest advancements, new norms, emerging trends and breakthrough topics from AACR by our expert panelists. Register: https://t.co/8zf4K3BgvW @AkoyaBio #ArtificialIntelligence #Cancer #Omics #TranslationalMedicine https://t.co/OlZmqsi19N